Huilin Tang, PhD
Postdoctoral Researcher
Huilin Tang, PhD, is a postdoctoral researcher at the Perelman School of Medicine, University of Pennsylvania. He earned his PhD in Pharmaceutical Outcomes and Policy from the University of Florida in 2024. His research centers on pharmacoepidemiology and real-world evidence, with a focus on diabetes and neurodegenerative diseases, aiming to advance precision medicine and support healthy aging.
Dr. Tang integrates large-scale real-world data sources—including electronic health records and insurance claims—with advanced methodologies such as artificial intelligence, machine learning, and causal inference to evaluate the effectiveness, safety, and heterogeneity of treatment effects for pharmaceutical therapies. He has authored more than 100 peer-reviewed publications, with his work featured in leading journals such as Annals of Internal Medicine, JAMA Neurology, Diabetes Care, and Alzheimer’s & Dementia.
Research Areas
Causal Inference, Large-Scale Cohorts, Artificial Intelligence/Machine Learning
Education
- PhD, University of Florida 2024
- M.S.Pharm, Peking University 2011
- B.S.Pharm, Xiamen University 2008
Contact
Research Highlights
- Newer Glucose-lowering Drugs and Risk of Alzheimer’s Disease and Related Dementia
Funded by the PhRMA Foundation Predoctoral Fellowship - Newer Glucose-lowering Drugs and Risk of Parkinson’s Disease
Funded by the American Foundation for Pharmaceutical Education Predoctoral Fellowship